SCHEMBL6313499

SCHEMBL6313499

O=C(O)C(=O)c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
ATM Q13315 1/20 0.56
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.43
PTPN1 P18031 1/20 0.43
PTGER4 P35408 1/20 0.42
CNR2 P34972 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948802 0.94 KDM4E (0.60) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL23948765 0.91 KDM4E (0.56) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL16271521 0.89 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1HPGD
Potassium Ion SCHEMBL6313935 0.88 KDM4E (0.53) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL31416092 0.87 KDM4E (0.69) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL21760735 0.87 KDM4E (0.69) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL13300206 0.84 HPGD (0.59) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL16271529 0.83 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL16271518 0.83 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL23948389 0.82 KDM4E (0.48) KDM4EL3MBTL1ATMALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960667-B2 Fluorescent maleimides and uses thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-01 US disclosed
US-20030189191-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2003-10-09 US disclosed
US-6508957-B2 Ultraviolet fluorescent material for void detection and for preparation of scintillators, films, luminescent solar energy collectors, organic electroluminescent devices, printing inks, electrophotographic toners CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-21 US disclosed
EP-1216285-A1 FLUORESCENT MALEIMIDES AND USES THEREOF Ciba SC Holding AG (CH) 2002-06-26 EP disclosed
US-20020065422-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2002-05-30 US disclosed
US-6258954-B1 ELECTROLUMINESCENCE; DETECTION VOIDS CIBA SPECIALTY CHEMICALS CORP. 2001-07-10 US disclosed
WO-2001019939-A1 FLUORESCENT MALEIMIDES AND USES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065422-A1 Fluorescent maleimides and uses thereof IK, PAH, MYO1F KDM4E 1873/4885L3MBTL1 4046/4885ATM 2045/4885
US-20030189191-A1 Fluorescent maleimides and uses thereof CBR1, CBR3, MT-CO2 KDM4E 2373/4885L3MBTL1 685/4885ATM 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.